1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. EDAP TMS S.A.
  6. News
  7. Summary
    EDAP   US2683111072

EDAP TMS S.A.

(EDAP)
  Report
Delayed Nasdaq  -  03:57 2022-08-11 pm EDT
7.320 USD   -2.27%
08/03EDAP TMS SA to Announce Second Quarter 2022 Financial Results on August 24th, 2022
GL
07/19European ADRs Rise in Tuesday Trading
MT
07/18European ADRs Move Higher in Monday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Nudge Lower in Tuesday Trading

06/28/2022 | 11:04am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ADAPTIMMUNE THERAPEUTICS PLC -2.17% 2.25 Delayed Quote.-40.00%
ASCENDIS PHARMA A/S 10.16% 104.81 Delayed Quote.-22.09%
BICYCLE THERAPEUTICS PLC -8.90% 25.91 Delayed Quote.-57.43%
CELLECTIS S.A. 6.46% 3.624 Real-time Quote.-51.29%
EDAP TMS S.A. -2.27% 7.32 Delayed Quote.22.20%
ENDAVA PLC 0.02% 110.34 Delayed Quote.-34.29%
EQUINOR ASA 2.46% 362 Real-time Quote.49.77%
ERYTECH PHARMA S.A. 2.06% 1.29 Real-time Quote.-39.15%
FORWARD PHARMA A/S 3.59% 3.75 Delayed Quote.-37.19%
GRIFOLS, S.A. 0.87% 13.84 Delayed Quote.-17.99%
MEREO BIOPHARMA GROUP PLC -4.96% 1.15 Delayed Quote.-28.13%
NUCANA PLC -3.23% 1.5 Delayed Quote.-36.97%
PRUDENTIAL PLC -0.42% 990 Delayed Quote.-22.32%
SHELL PLC 2.03% 2213.5 Delayed Quote.36.48%
TRIVAGO N.V. 2.94% 1.75 Delayed Quote.-19.72%
VERONA PHARMA PLC 8.26% 11.8 Delayed Quote.75.60%
All news about EDAP TMS S.A.
08/03EDAP TMS SA to Announce Second Quarter 2022 Financial Results on August 24th, 2022
GL
07/19European ADRs Rise in Tuesday Trading
MT
07/18European ADRs Move Higher in Monday Trading
MT
07/18EDAP Announces Focal One® HIFU Reimbursement Raised to Urology APC Level 6 Under CMS Ou..
GL
06/30European ADRs Fall Sharply in Thursday Trading
MT
06/28European ADRs Nudge Lower in Tuesday Trading
MT
06/28EDAP's Focal One® HIFU to be Showcased at Two Major Robotics & Urology International Co..
GL
06/28EDAP's Focal One® HIFU to be Showcased at Two Major Robotics & Urology International Co..
AQ
06/21European ADRs Rise Sharply in Tuesday Trading
MT
06/14EDAP holds a Symposium at 6th European Endometriosis Congress
GL
More news
Analyst Recommendations on EDAP TMS S.A.
More recommendations
Financials (USD)
Sales 2022 55,9 M - -
Net income 2022 -3,19 M - -
Net Debt 2022 - - -
P/E ratio 2022 -74,4x
Yield 2022 -
Capitalization 245 M 245 M -
Capi. / Sales 2022 4,38x
Capi. / Sales 2023 3,76x
Nbr of Employees 227
Free-Float 36,8%
Chart EDAP TMS S.A.
Duration : Period :
EDAP TMS S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EDAP TMS S.A.
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 7,32 $
Average target price 11,33 $
Spread / Average Target 54,8%
EPS Revisions
Managers and Directors
Marc Oczachowski Chief Operating Officer
Francois Dietsch Manager-Internal Audit & Consolidation
Frederic Pech Chief Operating Officer
Argil J. Wheelock Independent Director
Robert Michiels Independent Director
Sector and Competitors
1st jan.Capi. (M$)
EDAP TMS S.A.22.20%251
THERMO FISHER SCIENTIFIC-11.22%232 076
DANAHER CORPORATION-11.51%211 788
INTUITIVE SURGICAL, INC.-33.80%84 939
EDWARDS LIFESCIENCES CORPORATION-19.83%64 387
BOSTON SCIENTIFIC CORPORATION-3.41%59 927